YOLFTbeta
DV

Devyser Diagnostics AB

DVYSR · ST · Healthcare / Medical Devices

65.60SEK+0.60 (+0.92%)

Price History

Full chart

Market Stats

Previous Close65.00
Open65.10
Day Range65.10 – 67.70
52-Week Range50.10 – 148.00
Volume4.82K
Market Cap925.56M
P/E (TTM)59.57
Forward P/E25.00
EPS0.92
Dividend Yield0.00%
Beta0.78
50-Day Avg59.10
200-Day Avg82.01

About

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jan Wahlstrom
  • Employees110
  • HeadquartersBränningevägen 12, Årsta, Sweden, 120 54, Sweden
  • Websitehttps://devyser.com

Leadership

  • Mr. Jan WahlstromChief Executive Officer · b. 1967
  • Ms. Sabina BerlinChief Financial Officer · b. 1983
  • Mr. Michael Uhlin Ph.D.Chief Scientific Officer · b. 1978
  • Ms. Camilla WibergChief Human Resource Officer · b. 1979
  • Mr. John MuradVP & GM of Devyser US

Financials

Income Statement

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue48.15M64.30M65.69M93.48M126.61M169.30M216.90M250.50M
Growth (%)-+33.55%+2.16%+42.31%+35.44%+33.71%+28.12%+15.49%
Cost of Revenue13.35M12.03M9.04M18.82M20.84M21.20M44.20M48.60M
Gross Profit34.80M52.27M56.65M74.66M105.77M148.10M172.70M201.90M
Gross Margin72.28%81.29%86.24%79.87%83.54%87.48%79.62%80.60%
Operating Expense38.31M43.63M63.60M96.47M160.72M204.60M231.00M191.30M
Operating Income-3.51M8.65M-6.96M-21.81M-54.95M-56.50M-58.30M10.60M
Operating Margin-7.29%13.45%-10.59%-23.33%-43.40%-33.37%-26.88%4.23%
EBITDA1.61M13.26M-6.96M-18.05M-46.02M-43.80M-31.20M37.70M
EBITDA Margin3.34%20.62%-10.60%-19.31%-36.35%-25.87%-14.38%15.05%
Net Income519.00K7.01M-10.91M-20.73M-45.95M-53.60M-61.50M-8.40M
Net Income Margin1.08%10.90%-16.61%-22.17%-36.29%-31.66%-28.35%-3.35%
R&D8.62M9.90M21.70M20.82M28.64M41.10M43.10M18.00M
R&D as % of Total Revenue17.91%15.39%33.04%22.27%22.62%24.28%19.87%7.19%
Interest Expense596.00K785.00K925.00K939.00K500.00K800.00K3.50M13.60M
Interest Expense % of Total Revenue1.24%1.22%1.41%1.00%0.39%0.47%1.61%5.43%

Balance Sheet

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets48.22M73.70M74.36M456.87M500.63M510.10M473.80M469.70M
Total Liabilities18.25M36.69M43.58M40.18M69.19M125.00M124.80M115.40M
Total Equity29.97M37.01M30.77M416.68M431.44M385.10M349.10M354.30M
Cash7.54M10.38M8.34M377.64M363.60M262.90M144.50M77.50M
Total Debt9.72M23.87M21.50M12.96M21.20M74.80M59.10M51.90M
Net Debt2.18M13.49M13.16M-364.68M-342.40M-188.10M-85.40M-25.60M

Cash Flow

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.02M14.63M627.00K-16.48M-40.50M-69.70M-46.80M8.20M
Investing Cash Flow-5.06M-9.96M-4.71M-10.32M-23.86M-32.00M-76.90M-70.70M
Financing Cash Flow-974.00K-1.87M2.27M395.93M48.94M-200.00K7.80M-2.80M
Capital Expenditure5.06M9.31M3.41M8.80M25.80M32.00M76.90M1.50M
Free Cash Flow957.00K5.32M-2.79M-25.28M-66.30M-101.70M-123.70M6.70M
FCF to OCF15.90%36.35%-444.50%153.39%163.69%145.91%264.32%81.71%

Earnings

Report DateDec 14, 2021Feb 24, 2022May 11, 2022Aug 24, 2022Nov 10, 2022Feb 21, 2023May 9, 2023Aug 23, 2023Nov 9, 2023Feb 19, 2024May 8, 2024Jul 23, 2024Oct 30, 2024Feb 13, 2025Apr 29, 2025Jul 22, 2025Nov 4, 2025Feb 11, 2026Apr 27, 2026Jul 19, 2026Nov 3, 2026
EPS Estimate0.00-0.40-0.20-0.50-0.60-0.83-0.49-0.76-0.41-0.37-0.70-0.40-0.83-0.57-0.38-0.090.110.290.100.270.04
EPS Actual-0.32-0.87-0.39-0.90-0.55-1.04-0.83-0.57-0.24-0.53-0.75-1.41-0.91-0.19-0.850.05-0.120.580.120.07-
Surprise--117.50%-95.00%-80.00%8.33%-25.30%-69.39%25.00%41.46%-43.24%-7.14%-252.50%-9.64%66.67%-123.68%155.56%-209.09%100.00%12.88%-74.07%-
TimingAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market

Key Statistics & Ratios

Market Cap925.56M
Enterprise Value859.96M
Trailing P/E59.57
Forward P/E25.00
Price / Sales3.70
Price / Book2.35
EPS0.92
Book Value22.56
Revenue (TTM)250.30M
Gross Profit (TTM)195.70M
EBITDA32.50M
Profit Margin6.15%
Operating Margin-0.33%
Return on Equity4.28%
Return on Assets3.14%
Shares Outstanding16.89M
Shares Float7.43M
Beta0.78
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%